Alpha Teknova SEC Filings

Alpha Teknova, Inc. director Alexander Vos received a grant of options covering 55,000 shares of common stock as equity compensation. These non-qualified stock options have an exercise price of $5.37 per share and expire on June 1, 2036. The award vests in full on the first anniversary of the grant date, meaning Vos must remain in service for one year before any options become exercisable. This is a compensation-related grant, not an open-market purchase or sale of shares.

Alpha Teknova, Inc. director Brett Robertson received a grant of non-qualified stock options covering 55,000 shares of common stock. The options have an exercise price of $5.37 per share and expire on June 1, 2036. According to the disclosure, all 55,000 shares subject to the option will vest on the first anniversary of the grant date. After this grant, the filing shows Robertson holding options for 55,000 underlying shares directly.

Alpha Teknova, Inc. director Martha J. Demski received a grant of non-qualified stock options covering 55,000 shares of common stock. The options have an exercise price of $5.37 per share and expire on June 1, 2036. According to the footnote, all 55,000 shares underlying the option vest on the first anniversary of the grant date, so she must remain eligible until then to receive the full award.

Alpha Teknova, Inc. reported governance updates and voting results from its 2026 Annual Meeting of Stockholders. Director Irene Davis chose not to stand for re-election and retired from the Board and its Nominating and Corporate Governance Committee for personal and professional reasons, with no disagreement related to company matters.

Effective June 1, 2026, the Board reduced its size from eight to seven directors and decreased the number of Class II directors from three to two, and appointed existing director Ms. Demski to the Nominating and Corporate Governance Committee. At the meeting, 47,821,520 shares, representing 89.20% of common stock outstanding as of the record date, were represented.

Stockholders elected Class II directors J. Matthew Mackowski and Brett Robertson to serve until the 2029 annual meeting and ratified Grant Thornton LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.

Alpha Teknova, Inc. reported Q1 2026 revenue of $11.1 million, up from $9.8 million a year ago, driven by growth in both Lab Essentials and a strong 84.6% increase in Clinical Solutions. Gross margin improved to 34.2% from 30.7%, reflecting better profitability on higher volumes.

The company still posted a net loss of $4.6 million, similar to Q1 2025, though operating loss narrowed slightly. Teknova ended the quarter with $17.8 million in cash, cash equivalents, and short‑term investments, $24.8 million of working capital, and $13.2 million of term debt, and remained in compliance with loan covenants.

Alpha Teknova reported first quarter 2026 revenue of $11.1 million, up 13% from $9.8 million a year earlier, driven by growth in both major product lines. Lab Essentials revenue rose to $8.4 million, while Clinical Solutions nearly doubled to $2.1 million.

Gross margin improved to 34.2% from 30.7% as gross profit increased to $3.8 million. Operating expenses were $8.1 million, resulting in a net loss of $4.6 million, or $0.08 per share, similar to the prior year. Adjusted EBITDA was negative $2.0 million and Free Cash Outflow was $3.6 million, both better than 2025 levels.

The company ended the quarter with $17.8 million in cash and short-term investments and $13.2 million of total borrowings. Teknova reaffirmed its 2026 outlook for revenue of $42–44 million and expects full-year Free Cash Outflow of less than $10 million. The board also approved a refreshed Code of Business Conduct and Ethics focused on updates, clarifications, and administrative improvements.

Alpha Teknova, Inc. will hold its 2026 annual shareholder meeting in person at its Hollister, California offices on June 1, 2026 at 12:00 p.m. Pacific Time. Stockholders of record as of April 2, 2026, when 53,610,200 common shares were outstanding, may vote.

Investors are asked to elect three Class II directors (Irene Davis, J. Matthew Mackowski, and Brett Robertson) for terms running until the 2029 meeting and to ratify Grant Thornton LLP as independent auditor for the year ending December 31, 2026. A plurality vote elects directors, while auditor ratification requires a majority of votes present and entitled to vote.

The company is a Nasdaq “controlled company” because Telegraph Hill–affiliated funds hold a majority of the voting power, allowing exemptions from some independence requirements. Independent directors receive a $40,000 annual cash retainer plus committee fees and annual option grants, with overall board pay capped per the 2021 Equity Incentive Plan.

Alpha Teknova reported 2025 audit fees of $620,172 and audit-related fees of $12,840 for Grant Thornton. Executive pay for 2025 included salary, annual incentives, and equity awards for the CEO, CFO, and General Counsel, reflecting a mix of cash and long-term incentives.

Terrill Damon reported acquisition or exercise transactions in this Form 4 filing.

Alpha Teknova, Inc. reported that its General Counsel and Chief Compliance Officer, Terrill Damon, received a grant of non-qualified stock options covering 148,000 shares on February 15, 2026. The options were recorded at a price of $0.0000 per share in the filing.

According to the disclosure, all 148,000 options are held directly by Damon. A footnote explains that the shares underlying the option will vest in 48 equal monthly installments on the same day of each month after February 15, 2026, gradually becoming exercisable over four years.